Anti-Complement C5 Antibody (Ravulizumab)
Catalog No.
F1355
Anti-Complement C5 Antibody (Ravulizumab)
Featured Products
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity. Ravulizumab is used in the study of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.8 kDa
Dry ice
1803171-55-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Ultomiris, ravulizumab-cwvz, ALXN 1210
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01031
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human C5 His at 2 ug/mL can bind Anti-Complement C5 Antibody (Ravulizumab)
Complement C5
Please avoid freeze-thaw cycles.